Effect of pegylation on pharmaceuticals

JM Harris, RB Chess - Nature reviews Drug discovery, 2003 - nature.com
Protein and peptide drugs hold great promise as therapeutic agents. However, many are
degraded by proteolytic enzymes, can be rapidly cleared by the kidneys, generate …

Mechanisms of type-I-and type-II-interferon-mediated signalling

LC Platanias - Nature Reviews Immunology, 2005 - nature.com
Interferons are cytokines that have antiviral, antiproliferative and immunomodulatory effects.
Because of these important properties, in the past two decades, major research efforts have …

Intelligent model to predict early liver disease using machine learning technique

TM Ghazal, AU Rehman, M Saleem… - … for Technology and …, 2022 - ieeexplore.ieee.org
Liver Disease (LD) is the main cause of death worldwide, affecting a large number of
people. A variety of factors affect the liver, resulting in this disease. The diagnosis of this …

[HTML][HTML] Vital signs: hepatitis C treatment among insured adults—United States, 2019–2020

WW Thompson - MMWR. Morbidity and mortality weekly report, 2022 - cdc.gov
Introduction: Over 2 million adults in the United States have hepatitis C virus (HCV) infection,
and it contributes to approximately 14,000 deaths a year. Eight to 12 weeks of highly …

[HTML][HTML] Sexually transmitted infections treatment guidelines, 2021

KA Workowski - MMWR. Recommendations and Reports, 2021 - cdc.gov
These guidelines for the treatment of persons who have or are at risk for sexually transmitted
infections (STIs) were updated by CDC after consultation with professionals knowledgeable …

[PDF][PDF] Diagnosis, management, and treatment of hepatitis C: an update

MG Ghany, DB Strader, DL Thomas, LB Seeff - Hepatology, 2009 - Wiley Online Library
Background The hepatitis C virus (HCV) is a major public health problem and a leading
cause of chronic liver disease. 5 An estimated 180 million people are infected worldwide. 6 …

Prevalence of hepatitis C virus infection in US states and the District of Columbia, 2013 to 2016

ES Rosenberg, EM Rosenthal, EW Hall… - JAMA network …, 2018 - jamanetwork.com
Importance Infection with hepatitis C virus (HCV) is a major cause of morbidity and mortality
in the United States, and incidence has increased rapidly in recent years, likely owing to …

Current and future therapies for hepatitis C virus infection

TJ Liang, MG Ghany - New England Journal of Medicine, 2013 - Mass Medical Soc
Current and Future Therapies for Hepatitis C Virus Infection | New England Journal of Medicine
Skip to main content The New England Journal of Medicine homepage Advanced Search …

[PDF][PDF] Natural history of chronic hepatitis C

LB Seeff - Hepatology, 2002 - Wiley Online Library
Much controversy surrounds the issue of the natural history of hepatitis C virus (HCV)
infection. Many authorities view the disease as inexorably progressive with a high …

Delivery of therapeutic proteins

DS Pisal, MP Kosloski, SV Balu-Iyer - Journal of pharmaceutical sciences, 2010 - Elsevier
The safety and efficacy of protein therapeutics are limited by three interrelated
pharmaceutical issues, in vitro and in vivo instability, immunogenicity and shorter half-lives …